Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Wolfer

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer Research|March 17, 2011
MYC and metastasisAnita Wolfer, Sridhar Ramaswamy
Cell Cycle (Georgetown, Tex.)|October 9, 2010
Prognostic signatures, cancer metastasis and MYCAnita Wolfer, Sridhar Ramaswamy
Revue Medicale Suisse|June 14, 2013
[Endocrine therapy in breast cancer: efficacy and adverse events]Rahel Odermatt, Anita Wolfer, Khalil Zaman
Revue Medicale Suisse|January 23, 2025
[Oncology. Antibody-drug conjugates : a challenging innovation]Rita S Brito, Timothée Olivier, Anita Wolfer
The Oncologist|June 5, 2012
Severe peritonitis induced by methotrexate during treatment of persistent gestational trophoblastic diseaseStefan Zimmermann, Khalil Zaman, Anita Wolfer, et al.
Revue Medicale Suisse|October 31, 2018
[Actualities in endometrial carcinoma]Patrice Mathevet, Teresa Alvarez, Fernanda Herrera, et al.
Biomedicines|May 25, 2017
Cancer Vaccines in Ovarian Cancer: How Can We Improve?Silvia Martin Lluesma, Anita Wolfer, Alexandre Harari, et al.
Revue Medicale Suisse|May 17, 2018
[High grade serous ovarian cancer 2018 : advances and controversies]Nuria Mederos, Anita Wolfer, Patrice Mathevet, et al.
Immunity|July 18, 2002
Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage ThymocytesAnita Wolfer, Anne Wilson, Mohamed Nemir, et al.
Biochimica Et Biophysica Acta|May 1, 2013
The HER2 amplicon in breast cancer: Topoisomerase IIA and beyondWilliam Jacot, Maryse Fiche, Khalil Zaman, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer Research|March 17, 2011
MYC and metastasisAnita Wolfer, Sridhar Ramaswamy
Cell Cycle (Georgetown, Tex.)|October 9, 2010
Prognostic signatures, cancer metastasis and MYCAnita Wolfer, Sridhar Ramaswamy
Revue Medicale Suisse|June 14, 2013
[Endocrine therapy in breast cancer: efficacy and adverse events]Rahel Odermatt, Anita Wolfer, Khalil Zaman
Revue Medicale Suisse|January 23, 2025
[Oncology. Antibody-drug conjugates : a challenging innovation]Rita S Brito, Timothée Olivier, Anita Wolfer
The Oncologist|June 5, 2012
Severe peritonitis induced by methotrexate during treatment of persistent gestational trophoblastic diseaseStefan Zimmermann, Khalil Zaman, Anita Wolfer, et al.
Revue Medicale Suisse|October 31, 2018
[Actualities in endometrial carcinoma]Patrice Mathevet, Teresa Alvarez, Fernanda Herrera, et al.
Biomedicines|May 25, 2017
Cancer Vaccines in Ovarian Cancer: How Can We Improve?Silvia Martin Lluesma, Anita Wolfer, Alexandre Harari, et al.
Revue Medicale Suisse|May 17, 2018
[High grade serous ovarian cancer 2018 : advances and controversies]Nuria Mederos, Anita Wolfer, Patrice Mathevet, et al.
Immunity|July 18, 2002
Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage ThymocytesAnita Wolfer, Anne Wilson, Mohamed Nemir, et al.
Biochimica Et Biophysica Acta|May 1, 2013
The HER2 amplicon in breast cancer: Topoisomerase IIA and beyondWilliam Jacot, Maryse Fiche, Khalil Zaman, et al.
Pageof 3